EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

PEG-Modified Selenium Nanoparticles Dramatically Increases Antibody Binding Sites for Ultrasensitive Point-of-Care Detection of NT-proBNP

Lanju Wang, Jianing Ji, Yan Zhao, Xiaohui Chen, Jinbo Wu, Ruyan Meng, Yangguang Ren, Ying He, Guifang Long, Chunxia Chen, Zhizeng Wang iD, Yang Luo iD and 1 more

Analytical Chemistry · 2026-04-14 · 98 (14) · 10824-10835

DOI: 10.1021/acs.analchem.6c00653 ↗

At a glance

Journal article in Analytical Chemistry, published online on 2026-03-30. Written by Lanju Wang and 12 co-authors. Institution: Department of Blood Transfusion, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450000, People's Republic …. Major MEDLINE topics: Polyethylene Glycols, Selenium, Nanoparticles, Natriuretic Peptide, Brain. Cited 2 times so far (Crossref); 23 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Key Research and Development Program of China, Science and Technology Department of Henan Province, National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Portable disease monitoring is made possible by point-of-care testing (POCT), which can help prevent clinical deterioration. The widespread adoption of POCT, however, is limited by a shortage of efficient labeling probes. To address this, we developed monodisperse selenium nanoparticles (SeNPs) modified with polyethylene glycol (PEG-SeNPs) to improve their performance as labels. The nanoparticles transform from an aggregated to a monodisperse state after PEG regulation, with an average particle size of 50.23 ± 4.04 nm. This improvement increased the number of antibody binding sites on the surface of each nanoparticle from 34.2 to 91.6. Meanwhile, this study method's sensitivity, stability and accuracy have all greatly increased with the use of artificial intelligence analysis. Relative to conventional lateral flow immunoassay (LFIA) systems, the LOD of this research achieved 0.3 ng/mL for NT-proBNP detection without compromising stability and specificity. Clinical sample validation showed 97.85% agreement with a chemiluminescence immunoassay. As a result, the LFIA platform based on PEG-SeNPs has outstanding analytical performance and is a practical POCT approach for early disease detection, prognostic monitoring and evaluation in illness self-management.

Subjects

MeSH terms (MEDLINE)

Polyethylene GlycolsSeleniumNanoparticlesNatriuretic Peptide, BrainPeptide FragmentsPoint-of-Care SystemsHumansImmunoassayBinding Sites, AntibodyLimit of DetectionPoint-of-Care TestingRapid Diagnostic Tests

Substances

Polyethylene GlycolsSeleniumNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)

Authors and institutions

  • Department of Blood Transfusion, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou 450000, People's Republic of China.
  • Department of Laboratory Medicine, Chongqing Center for Clinical Laboratory, Chongqing Academy of Medical Sciences, Chongqing General Hospital, School of Medicine, Chongqing University, Chongqing 401147, People's Republ…
  • Joint National Laboratory for Antibody Drug Engineering, Clinical Laboratory of the First Affiliated Hospital, School of Medicine, Henan University, Kaifeng 475004, People's Republic of China.
  • Department of Laboratory Medicine, School of Medicine Jiangsu University, Zhenjiang 212013, People's Republic of China.
  • Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, People's Republic of China.
  • School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, People's Republic of China.

ORCID profiles: Zhizeng Wang, Yang Luo

Funding

  • National Key Research and Development Program of China
  • Science and Technology Department of Henan Province
  • National Natural Science Foundation of China
  • Henan Provincial Medical Science and Technology Research Program

Cite

APA

Wang, L., Ji, J., Zhao, Y., Chen, X., Wu, J., Meng, R., Ren, Y., He, Y., Long, G., Chen, C., Wang, Z., Luo, Y., & Shao, S. (2026). PEG-Modified Selenium Nanoparticles Dramatically Increases Antibody Binding Sites for Ultrasensitive Point-of-Care Detection of NT-proBNP. Analytical Chemistry, 98(14), 10824-10835. https://doi.org/10.1021/acs.analchem.6c00653

Vancouver

Wang L, Ji J, Zhao Y, Chen X, Wu J, Meng R, et al. PEG-Modified Selenium Nanoparticles Dramatically Increases Antibody Binding Sites for Ultrasensitive Point-of-Care Detection of NT-proBNP. Analytical Chemistry. 2026;98(14):10824-10835. doi:10.1021/acs.analchem.6c00653

BibTeX
@article{Wang2026,
  author = {Wang, Lanju and Ji, Jianing and Zhao, Yan and Chen, Xiaohui and Wu, Jinbo and Meng, Ruyan and Ren, Yangguang and He, Ying and Long, Guifang and Chen, Chunxia and Wang, Zhizeng and Luo, Yang and Shao, Shujun},
  title = {PEG-Modified Selenium Nanoparticles Dramatically Increases Antibody Binding Sites for Ultrasensitive Point-of-Care Detection of NT-proBNP},
  journal = {Analytical Chemistry},
  year = {2026},
  volume = {98},
  number = {14},
  pages = {10824--10835},
  doi = {10.1021/acs.analchem.6c00653}
}
Start for free →